Follow Us:

This educational activity is directed toward neurologists and other health care providers who care for patients with MS.
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of multiple sclerosis (MS) with a forward-looking perspective on how new and novel agents might impact clinical practice. The integration of biomarkers into diagnosis, efficacy of various disease-modifying therapies with a focus on the sphingosine-1-phosphate receptor modulator (S1PRM) class, and patient-focused risk assessment are presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements.
Upon completion of this activity, participants should be better able to: